DCF — PALMDALE REGIONAL MEDICAL CENTER
Enterprise Value: $-119.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-119.0M
Enterprise Value
$-43.3M
PV of Cash Flows
$-75.7M
PV of Terminal Value
$-121.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $243.1M | $-4.3M | -2.0% | $-14.6M | $-13.3M |
| Year 2 | $250.4M | $-1.9M | -1.0% | $-12.5M | $-10.4M |
| Year 3 | $257.9M | $0.6M | 0.0% | $-10.3M | $-7.8M |
| Year 4 | $265.7M | $1.9M | 1.0% | $-9.3M | $-6.4M |
| Year 5 | $273.6M | $2.7M | 1.0% | $-8.9M | $-5.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-119.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$236.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.022771397395017344
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5